| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |